SCHEMBL8324591

SCHEMBL8324591

CCC(O)(CC)c1ccc(OC)c(C=O)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
KDM4E B2RXH2 3/20 0.44
TSHR P16473 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
TUBB1 Q9H4B7 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
ERN1 O75460 6/20 0.40
TLR2 O60603 1/20 0.39
TLR1 Q15399 1/20 0.39
TLR6 Q9Y2C9 1/20 0.39
AOX1 Q06278 1/20 0.39
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
RAB9A P51151 1/20 0.38
PRKDC P78527 1/20 0.38
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
FDPS P14324 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14242951 0.83 ALDH1A1 (0.50) ALDH1A1KDM4ETSHRTDP1TUBB1
SCHEMBL7614307 0.82 ALDH1A1 (0.48) ALDH1A1KDM4ETSHRTDP1TUBB1
SCHEMBL16233094 0.80 ALDH1A1 (0.53) ALDH1A1KDM4ETSHRTDP1TUBB1
SCHEMBL3856515 0.80 L3MBTL1 (0.46) KDM4ETSHRL3MBTL1MEN1KMT2A
SCHEMBL14243152 0.79 ALDH1A1 (0.46) ALDH1A1KDM4ETSHRTDP1TUBB1
SCHEMBL15059172 0.78 CYP19A1 (0.50)
SCHEMBL31738417 0.78 ALDH1A1 (0.52) ALDH1A1KDM4ETSHRTDP1TUBB1
SCHEMBL4186655 0.78 ALDH1A1 (0.52) ALDH1A1KDM4ETSHRTDP1TUBB1
SCHEMBL7137868 0.78 ALDH1A1 (0.44) ALDH1A1KDM4ETSHRTDP1TUBB1
SCHEMBL1186123 0.77 ALDH1A1 (0.50) ALDH1A1KDM4ETSHRTDP1TUBB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004050080-A1 TREATMENT OF INFLAMMATORY DISORDERS WITH 2,3-BENZODIAZEPINES VELA PHARMACEUTICALS, INC. (US) 2004-06-17 WO disclosed
WO-2004050616-A2 TREATMENT OF IRRITABLE BOWEL SYNDROME AND NONULCER DYSPEPSIA WITH SUBSTITUTED 2,3-BENZODIAZEPINES VELA PHARMACEUTICALS, INC. (US) 2004-06-17 WO disclosed